Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All curcumin studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchCurcuminCurcumin (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Inhibitory effects of specific combination of natural compounds against SARS-CoV-2 and its Alpha, Beta, Gamma, Delta, Kappa, and Mu variants

Goc et al., European Journal of Microbiology and Immunology, doi:10.1556/1886.2021.00022
Jan 2022  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Curcumin for COVID-19
14th treatment shown to reduce risk in February 2021
 
*, now known with p = 0.000000046 from 26 studies.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,200+ studies for 70+ treatments. c19early.org
In Vitro study testing combinations of plant extracts and micronutrients with several variants of SARS-CoV-2. A combination of vitamin C, N-acetylcysteine, curcumin, quercetin, resveratrol, theaflavin, naringenin, baicalin, and broccoli extract showed the highest inhibition of RBD binding, and also decreased RdRp, furin, and cathepsin L activity.
In Silico studies predict inhibition of SARS-CoV-2 with curcumin or metabolites via binding to the spike Note A, Nag, Moschovou, Kandeil, Singh (B), Boseila (and specifically the receptor binding domain Note B, Kant, Srivastava, Eleraky), Mpro Note C, Moschovou, Kandeil, Srivastava, Naderi Beni, Rajagopal, Rampogu, Sekiou, Singh, Winih Kinasih, Thapa, Bahun, Eleraky, Boseila, RNA-dependent RNA polymerase Note D, Singh (C), Eleraky, ACE2 Note E, Singh (B), Thapa, Alkafaas, nucleocapsid Note F, Hidayah, Suravajhala, and nsp10 Note G, Suravajhala proteins. In Vitro studies demonstrate inhibition of the spike Note A, Mohd Abd Razak (and specifically the receptor binding domain Note B, Goc (B)), Mpro Note C, Bahun, Guijarro-Real, Mohd Abd Razak, Wu, ACE2 Note E, Goc (B), and TMPRSS2 Note H, Goc (B) proteins. In Vitro studies demonstrate efficacy in Calu-3 Note I, Bormann, A549 Note J, Mohd Abd Razak, 293T Note K, Zhang, HEK293-hACE2 Note L, Nittayananta, Wu, 293T/hACE2/TMPRSS2 Note M, Septisetyani, Vero E6 Note N, Bormann, Eleraky, Kandeil, Leka, Mohd Abd Razak, Nittayananta, Singh, Teshima, Marín-Palma, and SH-SY5Y Note O, Nicoliche cells. Curcumin is predicted to inhibit the interaction between the SARS-CoV-2 spike protein receptor binding domain and the human ACE2 receptor for the delta and omicron variants Kant, decreases pro-inflammatory cytokines induced by SARS-CoV-2 in peripheral blood mononuclear cells Marín-Palma, and alleviates SARS-CoV-2 spike protein-induced mitochondrial membrane damage and oxidative stress Zhang.
Study covers quercetin, curcumin, N-acetylcysteine, and vitamin C.
Goc et al., 21 Jan 2022, peer-reviewed, 5 authors.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
This PaperCurcuminAll
Inhibitory effects of specific combination of natural compounds against SARS-CoV-2 and its Alpha, Beta, Gamma, Delta, Kappa, and Mu variants
Anna Goc, Aleksandra Niedzwiecki, Vadim Ivanov, Svetlana Ivanova, Matthias Rath
doi:10.1556/1886.2021.00022
Despite vaccine availability, the global spread of COVID-19 continues, largely facilitated by emerging SARS-CoV-2 mutations. Our earlier research documented that a specific combination of plant-derived compounds can inhibit SARS-CoV-2 binding to its ACE2 receptor and controlling key cellular mechanisms of viral infectivity. In this study, we evaluated the efficacy of a defined mixture of plant extracts and micronutrients against original SARS-CoV-2 and its Alpha, Beta, Gamma, Delta, Kappa, and Mu variants. The composition containing vitamin C, N-acetylcysteine, resveratrol, theaflavin, curcumin, quercetin, naringenin, baicalin, and broccoli extract demonstrated a highest efficacy by inhibiting the receptor-binding domain (RBD) binding of SARS-CoV-2 to its cellular ACE2 receptor by 90%. In vitro exposure of test pseudo-typed variants to this formula for 1 h before or simultaneously administrated to human pulmonary cells resulted in up to 60% inhibition in their cellular entry. Additionally, this composition significantly inhibited other cellular mechanisms of viral infectivity, including the activity of viral RdRp, furin, and cathepsin L. These findings demonstrate the efficacy of natural compounds against SARS-CoV-2 including its mutated forms through pleiotropic mechanisms. Our results imply that simultaneous inhibition of multiple mechanisms of viral infection of host cells could be an effective strategy to prevent SARS-CoV-2 infection.
References
Andreano, Piccini, Licastro, Casalino, Johnson et al., SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma, Proc Natl Acad Sci, doi:10.1073/pnas.2103154118
Barbour, Rayya, Houssam, El-Hakim, Niedzwiecki et al., Alleviation of histopathologic effects of avian influenza virus by a specific nutrient synergy, Int J Appl Res Vet Med
Chakraborty, Maity, COVID-19 outbreak: migration, effects on society, global environment and prevention, Sci Total Environ, doi:10.1016/j.scitotenv.2020.138882
Collier, Marco, Ferreira, Meng, Datir et al., Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccineelicited antibodies, Nature, doi:10.1038/s41586-021-03412-7
Deryabin, Lvov, Botikov, Ivanov, Kalinovsky et al., Effects of a nutrient mixture on infectious properties of the highly pathogenic strain of avian influenza virus A/H5N1, Biofactors, doi:10.1002/biof.5520330201
Du, He, Zhou, Liu, Zheng et al., The spike protein of SARS-CoV-a target for vaccine and therapeutic development, Nat Rev Microbiol, doi:10.1038/nrmicro2090
Du, Yang, Zhou, Lu, Li et al., MERS-CoV spike protein: a key target for antivirals, Expert Opin Ther Targets, doi:10.1080/14728222.2017.1271415
Dyson, Hill, Moore, Curran-Sebastian, Tildesley et al., Possible future waves of SARS-CoV-2 infection generated by variants of concern with a range of characteristics, Nat Commun, doi:10.1038/s41467-021-25915-7
Fehr, Perlman, Coronaviruses: an overview of their replication and pathogenesis, Methods Mol Biol, doi:10.1007/978-1-4939-2438-7_1
Follis, York, Nunberg, Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry, Virology, doi:10.1016/j.virol.2006.02.003
Glowacka, Bertram, Müller, Allen, Soilleux et al., Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response, J Virol
Goc, Ivanov, Ivanova, Chatterjee, Rath et al., Simultaneous inhibition of SARS-CoV-2 infectivity by a specific combination of plant-derived compounds, Eur J Bio Biotech, doi:10.24018/ejbio.2021.2.5.258
Goc, Niedzwiecki, Rath, Polyunsaturated u-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry, Sci Rep, doi:10.1038/s41598-021-84850-1
Goc, Sumera, Rath, Niedzwiecki, Phenolic compounds disrupt spike-mediated receptor-binding and entry of SARS-CoV-2 pseudo-virions, PLOS ONE, doi:10.1371/journal.pone.0253489
Gopinath, Jokinen, Kurkinen, Pentikäinen, Screening of natural products targeting SARS-CoV-2-ACE2 receptor interface -A MixMD based HTVS pipeline, Front Chem, doi:10.3389/fchem.2020.589769
Ivanov, Goc, Ivanova, Niedzwiecki, Rath, Inhibition of ACE2 expression by Ascorbic acid alone and its combination with other natural compounds, Infect Dis Res Trmt (Auckl), doi:10.1177/1178633721994605
Ivanov, Ivanova, Niedzwiecki, Rath, Effective and safe global public health strategy to fight the COVID-19 pandemic: specific micronutrient combination inhibits Coronavirus cell-entry receptor (ACE2) expression, J Cell Med Nat Health
Jariwalla, Gangapurkar, Pandit, Kalinovsky, Niedzwiecki et al., Micronutrient cooperation in suppression of HIV production in chronically and latently infected cells, Mol Med Rep, doi:10.3892/mmr_00000268
Jariwalla, Roomi, Gangapurkar, Kalinovsky, Niedzwiecki et al., Suppression of influenza A virus nuclear antigen production and neuraminidase activity by a nutrient mixture containing ascorbic acid, green tea extract and amino acids, Biofactors, doi:10.1002/biof.5520310101
Johnson, Xie, Kumari, Lokugamage, Muruato et al., Furin cleavage site is key to SARS-CoV-2 pathogenesis, doi:10.1101/2020.08.26.268854%20Preprint
Li, Structure, function, and evolution of coronavirus spike proteins, Annu Rev Virol, doi:10.1146/annurev-virology-110615-042301
Liu, Luo, Libby, Shi, Cathepsin L-selective inhibitors: a potentially promising treatment for COVID-19 patients, Pharmacol Ther, doi:10.1016/j.pharmthera.2020.107587
Ming, Qiang, Involvement of spike protein, furin, and ACE2 in SARS-CoV-2-related cardiovascular complications, SN Compr Clin Med, doi:10.1007/s42399-020-00400-2
Muchtaridi, Fauzi, Ikram, Gazzali, Wahab, Natural flavonoids as potential angiotensin-converting enzyme 2 inhibitors for anti-SARS-CoV-2, Molecules, doi:10.3390/molecules25173980
Simmons, Gosalia, Rennekamp, Reeves, Diamond et al., Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry, Proc Natl Acad Sci
Tian, Huang, Fang, Wu, Furin DB: A database of 20-residue furin cleavage site motifs, substrates and their associated drugs, Int J Mol Sci, doi:10.3390/ijms12021060
Yang, Chen, Hamdoun, Coghi, Ng et al., Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding, Phytomedicine, doi:10.1016/j.phymed.2021.153591
Zhang, Cui, Li, Wang, Yu et al., Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization, Commun Biol, doi:10.1038/s42003-021-02728-4
Zhang, Hamdoun, Chen, Yang, Ip et al., Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with biolayer interferometry, Pharmacol Res, doi:10.1016/j.phrs.2021.105820
Zhang, Rao, Li, Zhu, Liu et al., High dose vitamin C infusion for the treatment of critically ill COVID-19, Ann Intensive Care, doi:10.1186/s13613-020-00792-3
{ 'DOI': '10.1556/1886.2021.00022', 'ISSN': ['2062-509X', '2062-8633'], 'URL': 'http://dx.doi.org/10.1556/1886.2021.00022', 'abstract': '<jats:title>Abstract</jats:title>\n' ' <jats:p>Despite vaccine availability, the global spread of COVID-19 continues, ' 'largely facilitated by emerging SARS-CoV-2 mutations. Our earlier research documented that a ' 'specific combination of plant-derived compounds can inhibit SARS-CoV-2 binding to its ACE2 ' 'receptor and controlling key cellular mechanisms of viral infectivity. In this study, we ' 'evaluated the efficacy of a defined mixture of plant extracts and micronutrients against ' 'original SARS-CoV-2 and its Alpha, Beta, Gamma, Delta, Kappa, and Mu variants. The ' 'composition containing vitamin C, N-acetylcysteine, resveratrol, theaflavin, curcumin, ' 'quercetin, naringenin, baicalin, and broccoli extract demonstrated a highest efficacy by ' 'inhibiting the receptor-binding domain (RBD) binding of SARS-CoV-2 to its cellular ACE2 ' 'receptor by 90%. <jats:italic>In vitro</jats:italic> exposure of test pseudo-typed variants ' 'to this formula for 1\u2009h before or simultaneously administrated to human pulmonary cells ' 'resulted in up to 60% inhibition in their cellular entry. Additionally, this composition ' 'significantly inhibited other cellular mechanisms of viral infectivity, including the ' 'activity of viral RdRp, furin, and cathepsin L. These findings demonstrate the efficacy of ' 'natural compounds against SARS-CoV-2 including its mutated forms through pleiotropic ' 'mechanisms. Our results imply that simultaneous inhibition of multiple mechanisms of viral ' 'infection of host cells could be an effective strategy to prevent SARS-CoV-2 ' 'infection.</jats:p>', 'author': [ { 'affiliation': [ { 'name': 'Dr. Rath Research Institute, 5941 Optical Ct., San Jose, CA ' '95138, USA'}], 'family': 'Goc', 'given': 'Anna', 'sequence': 'first'}, { 'ORCID': 'http://orcid.org/0000-0003-1275-8583', 'affiliation': [ { 'name': 'Dr. Rath Research Institute, 5941 Optical Ct., San Jose, CA ' '95138, USA'}], 'authenticated-orcid': True, 'family': 'Niedzwiecki', 'given': 'Aleksandra', 'sequence': 'additional'}, { 'affiliation': [ { 'name': 'Dr. Rath Research Institute, 5941 Optical Ct., San Jose, CA ' '95138, USA'}], 'family': 'Ivanov', 'given': 'Vadim', 'sequence': 'additional'}, { 'affiliation': [ { 'name': 'Dr. Rath Research Institute, 5941 Optical Ct., San Jose, CA ' '95138, USA'}], 'family': 'Ivanova', 'given': 'Svetlana', 'sequence': 'additional'}, { 'affiliation': [ { 'name': 'Dr. Rath Research Institute, 5941 Optical Ct., San Jose, CA ' '95138, USA'}], 'family': 'Rath', 'given': 'Matthias', 'sequence': 'additional'}], 'container-title': ['European Journal of Microbiology and Immunology'], 'content-domain': {'crossmark-restriction': True, 'domain': ['akjournals.com']}, 'created': {'date-parts': [[2022, 1, 21]], 'date-time': '2022-01-21T10:45:13Z', 'timestamp': 1642761913000}, 'deposited': { 'date-parts': [[2022, 1, 23]], 'date-time': '2022-01-23T02:42:05Z', 'timestamp': 1642905725000}, 'funder': [{'name': 'Dr. Rath Health Foundation'}], 'indexed': {'date-parts': [[2022, 1, 23]], 'date-time': '2022-01-23T03:11:22Z', 'timestamp': 1642907482391}, 'is-referenced-by-count': 0, 'issn-type': [{'type': 'print', 'value': '2062-509X'}, {'type': 'electronic', 'value': '2062-8633'}], 'issued': {'date-parts': [[2022, 1, 21]]}, 'license': [ { 'URL': 'https://creativecommons.org/licenses/by-nc/4.0/', 'content-version': 'unspecified', 'delay-in-days': 0, 'start': { 'date-parts': [[2022, 1, 21]], 'date-time': '2022-01-21T00:00:00Z', 'timestamp': 1642723200000}}], 'link': [ { 'URL': 'https://akjournals.com/view/journals/1886/aop/article-10.1556-1886.2021.00022/article-10.1556-1886.2021.00022.xml', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://akjournals.com/downloadpdf/journals/1886/aop/article-10.1556-1886.2021.00022/article-10.1556-1886.2021.00022.xml', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'syndication'}, { 'URL': 'https://akjournals.com/downloadpdf/journals/1886/aop/article-10.1556-1886.2021.00022/article-10.1556-1886.2021.00022.xml', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'member': '425', 'original-title': [], 'prefix': '10.1556', 'published': {'date-parts': [[2022, 1, 21]]}, 'published-print': {'date-parts': [[2022, 1, 21]]}, 'publisher': 'Akademiai Kiado Zrt.', 'reference': [ { 'DOI': '10.1038/nrmicro2090', 'article-title': 'The spike protein of SARS-CoV-a target for vaccine and therapeutic ' 'development', 'author': 'Du', 'doi-asserted-by': 'crossref', 'first-page': '226', 'journal-title': 'Nat Rev Microbiol', 'key': 'ref81', 'volume': '7', 'year': '2009'}, { 'DOI': '10.1007/s42399-020-00400-2', 'article-title': 'Involvement of spike protein, furin, and ACE2 in SARS-CoV-2-related ' 'cardiovascular complications', 'author': 'Ming', 'doi-asserted-by': 'crossref', 'first-page': '1103', 'journal-title': 'SN Compr Clin Med', 'key': 'ref251', 'volume': '2', 'year': '2020'}, { 'DOI': '10.1038/s41586-021-03412-7', 'article-title': 'Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies', 'author': 'Collier', 'doi-asserted-by': 'crossref', 'first-page': '136', 'journal-title': 'Nature', 'key': 'ref371', 'volume': '593', 'year': '2021'}, { 'DOI': '10.1128/JVI.02232-10', 'article-title': 'Evidence that TMPRSS2 activates the severe acute respiratory syndrome ' 'coronavirus spike protein for membrane fusion and reduces viral control ' 'by the humoral immune response', 'author': 'Glowacka', 'doi-asserted-by': 'crossref', 'first-page': '4122', 'journal-title': 'J Virol', 'key': 'ref111', 'volume': '85', 'year': '2011'}, { 'article-title': 'Inhibition of ACE2 expression by Ascorbic acid alone and its ' 'combination with other natural compounds', 'author': 'Ivanov', 'first-page': '1', 'journal-title': 'Infect Dis Res Trmt (Auckl)', 'key': 'ref201', 'volume': '14', 'year': '2021'}, { 'DOI': '10.1128/JVI.02232-10', 'article-title': 'Evidence that TMPRSS2 activates the severe acute respiratory syndrome ' 'coronavirus spike protein for membrane fusion and reduces viral control ' 'by the humoral immune response', 'author': 'Glowacka', 'doi-asserted-by': 'crossref', 'first-page': '4122', 'journal-title': 'J Virol', 'key': 'ref431', 'volume': '85', 'year': '2011'}, { 'DOI': '10.1007/978-1-4939-2438-7_1', 'article-title': 'Coronaviruses: an overview of their replication and pathogenesis', 'author': 'Fehr', 'doi-asserted-by': 'crossref', 'first-page': '1', 'journal-title': 'Methods Mol Biol', 'key': 'ref421', 'volume': '1282', 'year': '2015'}, { 'DOI': '10.3390/ijms12021060', 'article-title': 'A database of 20-residue furin cleavage site motifs, substrates and ' 'their associated drugs', 'author': 'Tian', 'doi-asserted-by': 'crossref', 'first-page': '1060', 'journal-title': 'Int J Mol Sci', 'key': 'ref221', 'volume': '12', 'year': '2011'}, { 'DOI': '10.1038/nrmicro2090', 'article-title': 'The spike protein of SARS-CoV-a target for vaccine and therapeutic ' 'development', 'author': 'Du', 'doi-asserted-by': 'crossref', 'first-page': '226', 'journal-title': 'Nat Rev Microbiol', 'key': 'ref401', 'volume': '7', 'year': '2009'}, { 'DOI': '10.1016/j.phrs.2021.105820', 'article-title': 'Identification of natural compounds as SARS-CoV-2 entry inhibitors by ' 'molecular docking-based virtual screening with bio-layer interferometry', 'author': 'Zhang', 'doi-asserted-by': 'crossref', 'first-page': '105820', 'journal-title': 'Pharmacol Res', 'key': 'ref131', 'volume': '172', 'year': '2021'}, { 'article-title': 'Furin cleavage site is key to SARS-CoV-2 pathogenesis', 'author': 'Johnson', 'first-page': '268854', 'journal-title': 'bioRxiv', 'key': 'ref241', 'year': '2020'}, { 'DOI': '10.1073/pnas.2103154118', 'article-title': 'SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent ' 'plasma', 'author': 'Andreano', 'doi-asserted-by': 'crossref', 'journal-title': 'Proc Natl Acad Sci USA', 'key': 'ref31', 'volume': '118', 'year': '2021'}, { 'DOI': '10.1016/j.phymed.2021.153591', 'article-title': 'Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding', 'author': 'Yang', 'doi-asserted-by': 'crossref', 'first-page': '153591', 'journal-title': 'Phytomedicine', 'key': 'ref161', 'volume': '87', 'year': '2021'}, { 'DOI': '10.1016/j.virol.2006.02.003', 'article-title': 'Furin cleavage of the SARS coronavirus spike glycoprotein enhances ' 'cell-cell fusion but does not affect virion entry', 'author': 'Follis', 'doi-asserted-by': 'crossref', 'first-page': '358', 'journal-title': 'Virology', 'key': 'ref551', 'volume': '350', 'year': '2006'}, { 'DOI': '10.1073/pnas.2103154118', 'article-title': 'SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent ' 'plasma', 'author': 'Andreano', 'doi-asserted-by': 'crossref', 'journal-title': 'Proc Natl Acad Sci USA', 'key': 'ref351', 'volume': '118', 'year': '2021'}, { 'article-title': 'Micronutrient cooperation in suppression of HIV production in ' 'chronically and latently infected cells', 'author': 'Jariwalla', 'first-page': '377', 'journal-title': 'Mol Med Rep', 'key': 'ref601', 'volume': '3', 'year': '2010'}, { 'article-title': 'Micronutrient cooperation in suppression of HIV production in ' 'chronically and latently infected cells', 'author': 'Jariwalla', 'first-page': '377', 'journal-title': 'Mol Med Rep', 'key': 'ref281', 'volume': '3', 'year': '2010'}, { 'DOI': '10.3390/molecules25173980', 'article-title': 'Natural flavonoids as potential angiotensin-converting enzyme 2 ' 'inhibitors for anti-SARS-CoV-2', 'author': 'Muchtaridi', 'doi-asserted-by': 'crossref', 'first-page': '3980', 'journal-title': 'Molecules', 'key': 'ref141', 'volume': '25', 'year': '2020'}, { 'DOI': '10.3389/fchem.2020.589769', 'article-title': 'Screening of natural products targeting SARS-CoV-2-ACE2 receptor ' 'interface -A MixMD based HTVS pipeline', 'author': 'Gopinath', 'doi-asserted-by': 'crossref', 'first-page': '589769', 'journal-title': 'Front Chem', 'key': 'ref151', 'volume': '8', 'year': '2020'}, { 'DOI': '10.1002/biof.5520310101', 'article-title': 'Suppression of influenza A virus nuclear antigen production and ' 'neuraminidase activity by a nutrient mixture containing ascorbic acid, ' 'green tea extract and amino acids', 'author': 'Jariwalla', 'doi-asserted-by': 'crossref', 'first-page': '1', 'journal-title': 'Biofactors', 'key': 'ref621', 'volume': '31', 'year': '2001'}, { 'DOI': '10.1038/s41586-021-03412-7', 'article-title': 'Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies', 'author': 'Collier', 'doi-asserted-by': 'crossref', 'first-page': '136', 'journal-title': 'Nature', 'key': 'ref51', 'volume': '593', 'year': '2021'}, { 'DOI': '10.24018/ejbio.2021.2.5.258', 'article-title': 'Simultaneous inhibition of SARS-CoV-2 infectivity by a specific ' 'combination of plant-derived compounds', 'author': 'Goc', 'doi-asserted-by': 'crossref', 'first-page': '24', 'journal-title': 'Eur J Bio Biotech', 'key': 'ref171', 'volume': '2', 'year': '2021'}, { 'DOI': '10.1080/14728222.2017.1271415', 'article-title': 'MERS-CoV spike protein: a key target for antivirals', 'author': 'Du', 'doi-asserted-by': 'crossref', 'first-page': '131', 'journal-title': 'Expert Opin Ther Targets', 'key': 'ref91', 'volume': '21', 'year': '2017'}, { 'DOI': '10.1016/j.phrs.2021.105820', 'article-title': 'Identification of natural compounds as SARS-CoV-2 entry inhibitors by ' 'molecular docking-based virtual screening with bio-layer interferometry', 'author': 'Zhang', 'doi-asserted-by': 'crossref', 'first-page': '105820', 'journal-title': 'Pharmacol Res', 'key': 'ref451', 'volume': '172', 'year': '2021'}, { 'DOI': '10.1002/biof.5520310101', 'article-title': 'Suppression of influenza A virus nuclear antigen production and ' 'neuraminidase activity by a nutrient mixture containing ascorbic acid, ' 'green tea extract and amino acids', 'author': 'Jariwalla', 'doi-asserted-by': 'crossref', 'first-page': '1', 'journal-title': 'Biofactors', 'key': 'ref301', 'volume': '31', 'year': '2001'}, { 'DOI': '10.1016/j.scitotenv.2020.138882', 'article-title': 'COVID-19 outbreak: migration, effects on society, global environment ' 'and prevention', 'author': 'Chakraborty', 'doi-asserted-by': 'crossref', 'first-page': '138882', 'journal-title': 'Sci Total Environ', 'key': 'ref01', 'volume': '728', 'year': '2020'}, { 'DOI': '10.1371/journal.pone.0253489', 'article-title': 'Phenolic compounds disrupt spike-mediated receptor-binding and entry of ' 'SARS-CoV-2 pseudo-virions', 'author': 'Goc', 'doi-asserted-by': 'crossref', 'journal-title': 'PLOS ONE', 'key': 'ref501', 'volume': '16', 'year': '2021'}, { 'DOI': '10.1002/biof.5520330201', 'article-title': 'Effects of a nutrient mixture on infectious properties of the highly ' 'pathogenic strain of avian influenza virus A/H5N1', 'author': 'Deryabin', 'doi-asserted-by': 'crossref', 'first-page': '85', 'journal-title': 'Biofactors', 'key': 'ref611', 'volume': '33', 'year': '2008'}, { 'DOI': '10.1371/journal.pone.0253489', 'article-title': 'Phenolic compounds disrupt spike-mediated receptor-binding and entry of ' 'SARS-CoV-2 pseudo-virions', 'author': 'Goc', 'doi-asserted-by': 'crossref', 'journal-title': 'PLOS ONE', 'key': 'ref181', 'volume': '16', 'year': '2021'}, { 'DOI': '10.1186/s13613-020-00792-3', 'article-title': 'High dose vitamin C infusion for the treatment of critically ill ' 'COVID-19', 'author': 'Zhang', 'doi-asserted-by': 'crossref', 'first-page': '5', 'journal-title': 'Ann Intensive Care', 'key': 'ref631', 'volume': '11', 'year': '2021'}, { 'DOI': '10.1080/14728222.2017.1271415', 'article-title': 'MERS-CoV spike protein: a key target for antivirals', 'author': 'Du', 'doi-asserted-by': 'crossref', 'first-page': '131', 'journal-title': 'Expert Opin Ther Targets', 'key': 'ref411', 'volume': '21', 'year': '2017'}, { 'DOI': '10.1146/annurev-virology-110615-042301', 'article-title': 'Structure, function, and evolution of coronavirus spike proteins', 'author': 'Li', 'doi-asserted-by': 'crossref', 'first-page': '237', 'journal-title': 'Annu Rev Virol', 'key': 'ref71', 'volume': '3', 'year': '2016'}, { 'DOI': '10.1038/s41598-021-84850-1', 'article-title': 'Polyunsaturated ω-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 ' 'binding and cellular entry', 'author': 'Goc', 'doi-asserted-by': 'crossref', 'first-page': '5207', 'journal-title': 'Sci Rep', 'key': 'ref191', 'volume': '11', 'year': '2021'}, { 'DOI': '10.1016/j.virol.2006.02.003', 'article-title': 'Furin cleavage of the SARS coronavirus spike glycoprotein enhances ' 'cell-cell fusion but does not affect virion entry', 'author': 'Follis', 'doi-asserted-by': 'crossref', 'first-page': '358', 'journal-title': 'Virology', 'key': 'ref231', 'volume': '350', 'year': '2006'}, { 'DOI': '10.1007/s42399-020-00400-2', 'article-title': 'Involvement of spike protein, furin, and ACE2 in SARS-CoV-2-related ' 'cardiovascular complications', 'author': 'Ming', 'doi-asserted-by': 'crossref', 'first-page': '1103', 'journal-title': 'SN Compr Clin Med', 'key': 'ref571', 'volume': '2', 'year': '2020'}, { 'DOI': '10.1016/j.scitotenv.2020.138882', 'article-title': 'COVID-19 outbreak: migration, effects on society, global environment ' 'and prevention', 'author': 'Chakraborty', 'doi-asserted-by': 'crossref', 'first-page': '138882', 'journal-title': 'Sci Total Environ', 'key': 'ref321', 'volume': '728', 'year': '2020'}, { 'DOI': '10.3389/fchem.2020.589769', 'article-title': 'Screening of natural products targeting SARS-CoV-2-ACE2 receptor ' 'interface -A MixMD based HTVS pipeline', 'author': 'Gopinath', 'doi-asserted-by': 'crossref', 'first-page': '589769', 'journal-title': 'Front Chem', 'key': 'ref471', 'volume': '8', 'year': '2020'}, { 'DOI': '10.1038/s41467-021-25915-7', 'article-title': 'Possible future waves of SARS-CoV-2 infection generated by variants of ' 'concern with a range of characteristics', 'author': 'Dyson', 'doi-asserted-by': 'crossref', 'first-page': '5730', 'journal-title': 'Nat Commun', 'key': 'ref61', 'volume': '12', 'year': '2021'}, { 'article-title': 'Alleviation of histopathologic effects of avian influenza virus by a ' 'specific nutrient synergy', 'author': 'Barbour', 'first-page': '9', 'journal-title': 'Int J Appl Res Vet Med', 'key': 'ref271', 'volume': '5', 'year': '2007'}, { 'DOI': '10.1038/s42003-021-02728-4', 'article-title': 'Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, ' 'animal tropism, and antibody neutralization', 'author': 'Zhang', 'doi-asserted-by': 'crossref', 'first-page': '1196', 'journal-title': 'Commun Biol', 'key': 'ref41', 'volume': '4', 'year': '2021'}, { 'DOI': '10.1146/annurev-virology-110615-042301', 'article-title': 'Structure, function, and evolution of coronavirus spike proteins', 'author': 'Li', 'doi-asserted-by': 'crossref', 'first-page': '237', 'journal-title': 'Annu Rev Virol', 'key': 'ref391', 'volume': '3', 'year': '2016'}, { 'DOI': '10.1073/pnas.0505577102', 'article-title': 'Inhibitors of cathepsin L prevent severe acute respiratory syndrome ' 'coronavirus entry', 'author': 'Simmons', 'doi-asserted-by': 'crossref', 'first-page': '11876', 'journal-title': 'Proc Natl Acad Sci', 'key': 'ref441', 'volume': '102', 'year': '2005'}, { 'DOI': '10.24018/ejbio.2021.2.5.258', 'article-title': 'Simultaneous inhibition of SARS-CoV-2 infectivity by a specific ' 'combination of plant-derived compounds', 'author': 'Goc', 'doi-asserted-by': 'crossref', 'first-page': '24', 'journal-title': 'Eur J Bio Biotech', 'key': 'ref491', 'volume': '2', 'year': '2021'}, { 'DOI': '10.1007/978-1-4939-2438-7_1', 'article-title': 'Coronaviruses: an overview of their replication and pathogenesis', 'author': 'Fehr', 'doi-asserted-by': 'crossref', 'first-page': '1', 'journal-title': 'Methods Mol Biol', 'key': 'ref101', 'volume': '1282', 'year': '2015'}, { 'article-title': 'Inhibition of ACE2 expression by Ascorbic acid alone and its ' 'combination with other natural compounds', 'author': 'Ivanov', 'first-page': '1', 'journal-title': 'Infect Dis Res Trmt (Auckl)', 'key': 'ref521', 'volume': '14', 'year': '2021'}, { 'DOI': '10.1016/j.phymed.2021.153591', 'article-title': 'Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding', 'author': 'Yang', 'doi-asserted-by': 'crossref', 'first-page': '153591', 'journal-title': 'Phytomedicine', 'key': 'ref481', 'volume': '87', 'year': '2021'}, { 'DOI': '10.1016/j.pharmthera.2020.107587', 'article-title': 'Cathepsin L-selective inhibitors: a potentially promising treatment for ' 'COVID-19 patients', 'author': 'Liu', 'doi-asserted-by': 'crossref', 'first-page': '107587', 'journal-title': 'Pharmacol Ther', 'key': 'ref211', 'volume': '213', 'year': '2020'}, { 'DOI': '10.1038/s42003-021-02728-4', 'article-title': 'Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, ' 'animal tropism, and antibody neutralization', 'author': 'Zhang', 'doi-asserted-by': 'crossref', 'first-page': '1196', 'journal-title': 'Commun Biol', 'key': 'ref361', 'volume': '4', 'year': '2021'}, { 'article-title': 'Furin cleavage site is key to SARS-CoV-2 pathogenesis', 'author': 'Johnson', 'first-page': '268854', 'journal-title': 'bioRxiv', 'key': 'ref561', 'year': '2020'}, { 'article-title': 'Effective and safe global public health strategy to fight the COVID-19 ' 'pandemic: specific micronutrient combination inhibits Coronavirus ' 'cell-entry receptor (ACE2) expression', 'author': 'Ivanov', 'journal-title': 'J Cell Med Nat Health', 'key': 'ref261', 'year': '2020'}, { 'DOI': '10.1002/biof.5520330201', 'article-title': 'Effects of a nutrient mixture on infectious properties of the highly ' 'pathogenic strain of avian influenza virus A/H5N1', 'author': 'Deryabin', 'doi-asserted-by': 'crossref', 'first-page': '85', 'journal-title': 'Biofactors', 'key': 'ref291', 'volume': '33', 'year': '2008'}, { 'DOI': '10.1038/s41467-021-25915-7', 'article-title': 'Possible future waves of SARS-CoV-2 infection generated by variants of ' 'concern with a range of characteristics', 'author': 'Dyson', 'doi-asserted-by': 'crossref', 'first-page': '5730', 'journal-title': 'Nat Commun', 'key': 'ref381', 'volume': '12', 'year': '2021'}, { 'article-title': 'Effective and safe global public health strategy to fight the COVID-19 ' 'pandemic: specific micronutrient combination inhibits Coronavirus ' 'cell-entry receptor (ACE2) expression', 'author': 'Ivanov', 'journal-title': 'J Cell Med Nat Health', 'key': 'ref581', 'year': '2020'}, { 'DOI': '10.1186/s13613-020-00792-3', 'article-title': 'High dose vitamin C infusion for the treatment of critically ill ' 'COVID-19', 'author': 'Zhang', 'doi-asserted-by': 'crossref', 'first-page': '5', 'journal-title': 'Ann Intensive Care', 'key': 'ref311', 'volume': '11', 'year': '2021'}, { 'article-title': 'Alleviation of histopathologic effects of avian influenza virus by a ' 'specific nutrient synergy', 'author': 'Barbour', 'first-page': '9', 'journal-title': 'Int J Appl Res Vet Med', 'key': 'ref591', 'volume': '5', 'year': '2007'}, { 'DOI': '10.1038/s41598-021-84850-1', 'article-title': 'Polyunsaturated ω-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 ' 'binding and cellular entry', 'author': 'Goc', 'doi-asserted-by': 'crossref', 'first-page': '5207', 'journal-title': 'Sci Rep', 'key': 'ref511', 'volume': '11', 'year': '2021'}, { 'DOI': '10.3390/molecules25173980', 'article-title': 'Natural flavonoids as potential angiotensin-converting enzyme 2 ' 'inhibitors for anti-SARS-CoV-2', 'author': 'Muchtaridi', 'doi-asserted-by': 'crossref', 'first-page': '3980', 'journal-title': 'Molecules', 'key': 'ref461', 'volume': '25', 'year': '2020'}, { 'DOI': '10.1016/j.pharmthera.2020.107587', 'article-title': 'Cathepsin L-selective inhibitors: a potentially promising treatment for ' 'COVID-19 patients', 'author': 'Liu', 'doi-asserted-by': 'crossref', 'first-page': '107587', 'journal-title': 'Pharmacol Ther', 'key': 'ref531', 'volume': '213', 'year': '2020'}, { 'DOI': '10.1073/pnas.0505577102', 'article-title': 'Inhibitors of cathepsin L prevent severe acute respiratory syndrome ' 'coronavirus entry', 'author': 'Simmons', 'doi-asserted-by': 'crossref', 'first-page': '11876', 'journal-title': 'Proc Natl Acad Sci', 'key': 'ref121', 'volume': '102', 'year': '2005'}, { 'DOI': '10.3390/ijms12021060', 'article-title': 'A database of 20-residue furin cleavage site motifs, substrates and ' 'their associated drugs', 'author': 'Tian', 'doi-asserted-by': 'crossref', 'first-page': '1060', 'journal-title': 'Int J Mol Sci', 'key': 'ref541', 'volume': '12', 'year': '2011'}], 'reference-count': 60, 'references-count': 60, 'relation': {}, 'score': 1, 'short-container-title': ['EuJMI'], 'short-title': [], 'source': 'Crossref', 'subtitle': [], 'title': [ 'Inhibitory effects of specific combination of natural compounds against SARS-CoV-2 and its ' 'Alpha, Beta, Gamma, Delta, Kappa, and Mu variants'], 'type': 'journal-article', 'update-policy': 'http://dx.doi.org/10.1556/policypage.crossmark.crossref.1'}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit